Matt Gline
PersonHeard in 1 episode across 1 show since Oct 2026
Matt Gline is the Chief Executive Officer of Roivant Sciences, a biotechnology company. He joined Roivant in 2016 and previously served as its Chief Financial Officer.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
Email alert
Email me when Matt Gline comes up on a podcast
One email a week at most, with the new episodes that mention Matt Gline. Free, no account needed, unsubscribe in one click.
What Matt Gline has said on podcasts
5 statements
Dario or Anthropic will eventually enter or transform pharmaceuticals.
“Dario or Anthropic would eventually experience pharma”
Open the episode · Episode 200 - October 23, 2026Listen at 14:53
Moderna’s recent price movements may have been driven mainly by market technicals, not fundamental value.
“it was entirely technical explanation for what had happened that had relatively little to do with either Moderna's actual value or anybody else's actual value”
Open the episode · Episode 200 - October 23, 2026Listen at 16:21
Biotech progress is driven primarily by incremental work from operational teams.
“it's an industry that's a game of inches propelled by the people on the ground doing the work”
Open the episode · Episode 200 - October 23, 2026Listen at 36:22
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Matt Gline, newest first
